Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 21,410 | 21,219 | 18,852 | 17,894 | 16,894 |
| Cost of Goods | 9,117 | 9,173 | 7,945 | 7,553 | 6,798 |
| Gross Profit | 12,293 | 12,046 | 10,907 | 10,341 | 10,096 |
| Operating Expenses | 29,846 | 29,810 | 28,505 | 27,202 | 26,448 |
| Operating Income | -17,436 | -17,591 | -16,653 | -16,308 | -15,554 |
| Interest Expense | 2,054 | 1,847 | 1,109 | 849 | 749 |
| Other Income | 717 | 537 | -89 | -232 | -74 |
| Pre-tax Income | -18,773 | -18,901 | -17,851 | -17,389 | -16,377 |
| Income Tax | 29 | -26 | 21 | 106 | 22 |
| Net Income Continuous | -18,802 | -18,875 | -17,872 | -17,495 | -16,399 |
| Net Income | $-18,802 | $-18,875 | $-17,872 | $-17,495 | $-16,399 |
| EPS Basic Total Ops | -0.49 | -0.49 | -0.47 | -0.47 | -0.44 |
| EPS Basic Continuous Ops | -0.49 | -0.50 | -0.47 | -0.47 | -0.44 |
| EPS Diluted Total Ops | -0.49 | -0.49 | -0.47 | -0.47 | -0.44 |
| EPS Diluted Continuous Ops | -0.49 | -0.50 | -0.47 | -0.47 | -0.44 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.50 | -0.47 | N/A | N/A |
| EBITDA(a) | $-15,315 | $-15,690 | $-14,714 | $-14,618 | $-13,935 |